✦ LIBER ✦

Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study

✍ Scribed by Stass, Heino; Weimann, Boris; Nagelschmitz, Johannes; Rolinck-Werninghaus, Claudia; Staab, Doris

Book ID: 122144096
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 276 KB
Volume: 35
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2013.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB

A phase I dose escalation study of the p

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours

✍ Edwina N. Scott; Anne L. Thomas; L. Rhoda Molife; Samreen Ahmed; Sarah Blagden; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 253 KB

Pharmacokinetic and pharmacodynamic prop

Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: A phase I, open-label, dose-escalation clinical study

✍ Daniel J. Burge; Stephen A. Bookbinder; Alan J. Kivitz; Roy M. Fleischmann; Cath 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Efficacy, tolerability, and effect on as

Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study

✍ William Busse; Bernard Levine; Kim Andriano; Catherine Lavecchia; Ümit Yegen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 903 KB

A phase I, double-blind, randomized, pla

A phase I, double-blind, randomized, placebo-controlled study to investigate the safety tolerability and pharmacokinetic profile of S-3304, a matrix metalloproteinase inhibitor, when given in multiple doses with high doses for 4 weeks to healthy volunteers

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB

A Double-Blind, Randomized Placebo-Contr

A Double-Blind, Randomized Placebo-Controlled Phase II Study of the Pharmacodynamics, Safety/Tolerability, and Pharmacokinetics of Single Doses of the Motilin Agonist GSK962040, in Patients With Type I Diabetes Mellitus (T1DM) and Gastroparesis

✍ Hellström, Per M. ;Tack, Jan F. ;Stephens, Kimberley E. ;Barton, Matthew E. ;Vas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB